1 |
[tolvaptan 15] |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 [1] 67 💬 |
2 |
[tolvaptan 30] |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 [1] 67 💬 |
3 |
[tolvaptan 45/15] |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 [1] 67 💬 |
4 |
Biological sampling |
- |
- |
- |
- |
065 [1] 65 💬 |
5 |
Biological samplings |
- |
- |
- |
- |
096 [1] 96 💬 |
6 |
Blood and stools samples |
- |
- |
- |
- |
096 [1] 96 💬 |
7 |
Blood sample |
- |
- |
- |
- |
008 [13] 8 , 13, 46, 49, 51, 53, 61, 66, 84, 97, 274, 288, 299 💬 |
8 |
Blood sample and environmental survey |
- |
- |
- |
- |
002 [1] 2 💬 |
9 |
Blood sample collection |
- |
- |
- |
- |
085 [1] 85 💬 |
10 |
Blood samples |
- |
- |
- |
- |
013 [8] 13, 41, 46, 51, 61, 97, 227, 271 💬 |
11 |
Blood sampling |
- |
- |
- |
- |
013 [5] 13, 17, 19, 51, 96 💬 |
12 |
Bnp blood sample test |
- |
- |
- |
- |
058 [1] 58 💬 |
13 |
Culture of lymphoblastoid line from blood sample |
- |
- |
- |
- |
102 [1] 102 💬 |
14 |
Device: 30-hour ambulatory sampling of intestinal fluid |
- |
- |
- |
- |
083 [1] 83 💬 |
15 |
Device: frequently sampled oral glucose tolerance test and cgm |
Dextrose, unspecified form |
- |
- |
- |
299 [1] 299 💬 |
16 |
Diagnostic test: auto-assessment manikins (sam) |
- |
- |
- |
- |
006 [1] 6 💬 |
17 |
Diagnostic test: blood sample , doppler of uterine vessel and placenta |
- |
- |
- |
- |
288 [1] 288 💬 |
18 |
Dried blood spot (dbs) sampling |
- |
- |
- |
- |
019 [1] 19 💬 |
19 |
Extra blood draw samples |
- |
- |
- |
- |
300 [1] 300 💬 |
20 |
Faecal sampling |
- |
- |
- |
- |
046 [1] 46 💬 |
21 |
Genetic: blood or saliva sample collection |
- |
- |
- |
- |
299 [1] 299 💬 |
22 |
Jinarc - tolvaptan tablets |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 [1] 67 💬 |
23 |
One additional blood sample during a planned blood test |
- |
- |
- |
- |
266 [1] 266 💬 |
24 |
Opc-41061 (tolvaptan) |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 [1] 67 💬 |
25 |
Other: biological samples |
- |
- |
- |
- |
206 [1] 206 💬 |
26 |
Other: blood sample |
- |
- |
- |
- |
299 [1] 299 💬 |
27 |
Other: blood sample and cotton skin swabs |
Cotton |
- |
- |
- |
162 [1] 162 💬 |
28 |
Other: blood samples |
- |
- |
- |
- |
093 [1] 93 💬 |
29 |
Other: blood sampling for laboratory developed test (ldt) analysis |
- |
- |
- |
- |
065 [1] 65 💬 |
30 |
Other: bronchoalveolar samples |
- |
- |
- |
- |
051 [1] 51 💬 |
31 |
Other: review of past medical history, clinical exam, and electroencephalogram, polysomnography and urine samples of melatonin and pupillometry. |
Melatonin |
[1] D08170 D08170 💬 |
MTNR1A [2] MTNR1A, MTNR1B 💬 |
Circadian entrainment [2] Circadian entrainment, Neuroactive ligand-receptor interaction |
149 [1] 149 💬 |
32 |
Other: sputum sample |
- |
- |
- |
- |
299 [1] 299 💬 |
33 |
Other: stool sample |
- |
- |
- |
- |
006 [2] 6 , 299 💬 |
34 |
Procedure: 2 ml of whole blood sample will be collected on edta tube |
Edetic acid |
[8] D00052 D00052, D00571 D00571, D01802 D01802, D03943 D03943, D03944 D03944, D03945 D03945, D03946 D03946, D03947 D03947 💬 |
- |
- |
051 [1] 51 💬 |
35 |
Procedure: biofluid samplings |
- |
- |
- |
- |
006 [1] 6 💬 |
36 |
Procedure: blood sample |
- |
- |
- |
- |
065 [1] 65 💬 |
37 |
Procedure: blood sampling for determination of serum zn |
- |
- |
- |
- |
299 [1] 299 💬 |
38 |
Procedure: blood sampling from infant |
- |
- |
- |
- |
046 [3] 46, 96, 271 💬 |
39 |
Procedure: blood sampling from mother |
- |
- |
- |
- |
046 [3] 46, 96, 271 💬 |
40 |
Procedure: blood sampling from umbilical cord |
- |
- |
- |
- |
046 [3] 46, 96, 271 💬 |
41 |
Procedure: blood sampling, endoscopy |
- |
- |
- |
- |
097 [1] 97 💬 |
42 |
Procedure: breast milk sampling |
- |
- |
- |
- |
046 [3] 46, 96, 271 💬 |
43 |
Procedure: skin biopsy for the primary fibroblast culture and a 15 ml blood sample (3 unnamed samples of 5ml) in each of the 4 srt patients included. |
- |
- |
- |
- |
102 [1] 102 💬 |
44 |
Procedure: spleen sample |
- |
- |
- |
- |
061 [1] 61 💬 |
45 |
Procedure: stool samples |
- |
- |
- |
- |
097 [1] 97 💬 |
46 |
Procedure: tissue samplings |
- |
- |
- |
- |
006 [1] 6 💬 |
47 |
S-adenosyl-methionine (same) capsules |
Ademetionine |
[3] D00019 D00019, D04983 D04983, D07128 D07128 💬 |
- |
- |
093 [1] 93 💬 |
48 |
Sam |
- |
- |
- |
- |
006 [1] 6 💬 |
49 |
Sam-e |
Ademetionine |
[1] D07128 D07128 💬 |
- |
- |
006 [1] 6 💬 |
50 |
Same |
Ademetionine |
[1] D07128 D07128 💬 |
- |
- |
093 [1] 93 💬 |
51 |
Samsca |
- |
- |
- |
- |
067 [2] 67, 72 💬 |
52 |
Samsca 15 mg tablets |
- |
- |
- |
- |
067 [1] 67 💬 |
53 |
Samsca 30 mg tablets |
- |
- |
- |
- |
067 [1] 67 💬 |
54 |
Samsca*10cpr 15mg |
- |
- |
- |
- |
072 [1] 72 💬 |
55 |
The pop02 study is collecting bodily fluid samples (i.e., whole blood, effluent samples) of children prescribed the following drugs of interest per standard of care: |
- |
- |
- |
- |
086 [1] 86 💬 |
56 |
Tolvaptan |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 [3] 67, 72, 225 💬 |
57 |
Tolvaptan (opc-41061) |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 [1] 67 💬 |
58 |
Tolvaptan 15 |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 [1] 67 💬 |
59 |
Tolvaptan 15 mg tablet |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 [1] 67 💬 |
60 |
Tolvaptan 15 mg tablets |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 [1] 67 💬 |
61 |
Tolvaptan 15mg |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 [1] 67 💬 |
62 |
Tolvaptan 30 |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 [1] 67 💬 |
63 |
Tolvaptan 30 mg tablet |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 [1] 67 💬 |
64 |
Tolvaptan 30 mg tablets |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 [1] 67 💬 |
65 |
Tolvaptan 30mg |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 [1] 67 💬 |
66 |
Tolvaptan 45/15 |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 [1] 67 💬 |
67 |
Tolvaptan 60/30 |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 [1] 67 💬 |
68 |
Tolvaptan 7.5 mg tablet |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 [1] 67 💬 |
69 |
Tolvaptan in euvolemic hyponatremia |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
072 [1] 72 💬 |
70 |
Tolvaptan ir |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 [1] 67 💬 |
71 |
Tolvaptan mr |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 [1] 67 💬 |
72 |
Tolvaptan oral tablet |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
072 [1] 72 💬 |
73 |
Urine sample |
- |
- |
- |
- |
049 [3] 49, 51, 61 💬 |
74 |
Urine samples |
- |
- |
- |
- |
013 [1] 13 💬 |
75 |
Urine samples taken to measure methotrexate and its major metabolite 7-oh-methotrexate level |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
76 |
Venous blood sample |
- |
- |
- |
- |
046 [1] 46 💬 |
77 |
Whole blood sample |
- |
- |
- |
- |
177 [1] 177 💬 |